TrialHIV medicine2015

Baseline prevalence and predictors of liver fibrosis among HIV-positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

G V Matthews et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.